1. Home
  2. SPRO vs QMCO Comparison

SPRO vs QMCO Comparison

Compare SPRO & QMCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRO
  • QMCO
  • Stock Information
  • Founded
  • SPRO 2013
  • QMCO 1980
  • Country
  • SPRO United States
  • QMCO United States
  • Employees
  • SPRO N/A
  • QMCO N/A
  • Industry
  • SPRO Biotechnology: Pharmaceutical Preparations
  • QMCO Electronic Components
  • Sector
  • SPRO Health Care
  • QMCO Technology
  • Exchange
  • SPRO Nasdaq
  • QMCO Nasdaq
  • Market Cap
  • SPRO 121.0M
  • QMCO 98.8M
  • IPO Year
  • SPRO 2017
  • QMCO N/A
  • Fundamental
  • Price
  • SPRO $1.90
  • QMCO $7.36
  • Analyst Decision
  • SPRO Buy
  • QMCO Hold
  • Analyst Count
  • SPRO 4
  • QMCO 2
  • Target Price
  • SPRO $5.00
  • QMCO $19.00
  • AVG Volume (30 Days)
  • SPRO 391.2K
  • QMCO 636.7K
  • Earning Date
  • SPRO 08-12-2025
  • QMCO 09-10-2025
  • Dividend Yield
  • SPRO N/A
  • QMCO N/A
  • EPS Growth
  • SPRO N/A
  • QMCO N/A
  • EPS
  • SPRO N/A
  • QMCO N/A
  • Revenue
  • SPRO $48,576,000.00
  • QMCO $266,079,000.00
  • Revenue This Year
  • SPRO N/A
  • QMCO $7.49
  • Revenue Next Year
  • SPRO N/A
  • QMCO $3.22
  • P/E Ratio
  • SPRO N/A
  • QMCO N/A
  • Revenue Growth
  • SPRO N/A
  • QMCO N/A
  • 52 Week Low
  • SPRO $0.51
  • QMCO $2.88
  • 52 Week High
  • SPRO $3.22
  • QMCO $90.64
  • Technical
  • Relative Strength Index (RSI)
  • SPRO 39.50
  • QMCO 46.24
  • Support Level
  • SPRO $1.91
  • QMCO $7.07
  • Resistance Level
  • SPRO $2.18
  • QMCO $8.62
  • Average True Range (ATR)
  • SPRO 0.10
  • QMCO 0.42
  • MACD
  • SPRO 0.01
  • QMCO 0.07
  • Stochastic Oscillator
  • SPRO 19.18
  • QMCO 21.74

About SPRO Spero Therapeutics Inc.

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. Besides, it is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.

About QMCO Quantum Corporation

Quantum Corp is a United States-based company that delivers end-to-end data management solutions designed for unstructured data in the era of artificial intelligence (AI). It provides one of the comprehensive and cost-efficient solutions for the entire data lifecycle. The group provides solutions for video, images, audio, and other large files because this unstructured data represents. Its portfolio of products includes primary storage software and systems, secondary storage software and systems, as well as devices and media. The group operates in three geographic regions: Americas, Europe, the Middle East, and Africa (EMEA), and Asia Pacific (APAC).

Share on Social Networks: